The Diabetes Prevention Gap And Opportunities To Increase Participation In Effective Interventions.
The Diabetes Prevention Gap And Opportunities To Increase Participation In Effective Interventions.
复制标题
DOI：
10.1377/hlthaff.2022.00259
复制
发表时间：
2022-07
期刊：
影响因子：
9.7
通讯作者：
Galaviz, Karla, I
中科院分区：
文献类型：
--
作者：
Alva, Maria L.;Chakkalakal, Rosette J.;Moln, Tannaz;Galaviz, Karla, I
为了了解美国糖尿病前期负担和治疗的现状，我们研究了糖尿病前期患病率、检测和预防资源获取方面的最新趋势。我们使用全国调查数据估计，在美国成年人口中，被诊断为糖尿病前期的患病率为13.5%。尽管从2010年到2020年，糖尿病前期患病率上升了4.8个百分点，但获得预防资源的机会仍然很少。最有效的糖尿病预防干预措施，也就是众所周知的国家糖尿病预防计划，仍然严重供应不足和使用不足。全国只有2098家国家糖尿病预防计划认可的提供者，只有3%的糖尿病前期成年人参与了该计划。我们建议采取三项行动来加强预防工作：增加预防干预的支出，以避免供应扭曲；改善数据整合和患者随访；扩大预防干预的覆盖范围和机会。这些行动需要在政策层面做出改变，可以降低预防的障碍。
To understand the current state of prediabetes burden and treatment in the US, we examined recent trends in prediabetes prevalence, testing, and access to preventive resources. We estimated 13.5 percent prevalence of diagnosed prediabetes in the overall US adult population, using national survey data. Although prediabetes prevalence increased by 4.8 percentage points from 2010 to 2020, access to preventive resources remained low. The most effective intervention for diabetes prevention, known as the National Diabetes Prevention Program, remained woefully undersupplied and underused. There are only 2,098 National Diabetes Prevention Program–recognized providers nationally, and only 3 percent of adults with prediabetes have participated in the program. We suggest three actions to augment prevention efforts: increase payment for prevention interventions to avoid supply distortions, improve data integration and patient follow-up, and extend coverage and broaden access for preventive interventions. These actions, which would require policy-level changes, could lower the barriers to prevention.
登录
查看更多内容
影响因子：
16.2
作者：
Diabetes Prevention Program Research Group
通讯作者：
Diabetes Prevention Program Research Group
影响因子：
13.8
作者：
Ali, Mohammed K.;Bullard, Kai McKeever;Gregg, Edward W.
通讯作者：
Gregg, Edward W.
影响因子：
16.2
作者：
Ely EK;Gruss SM;Luman ET;Gregg EW;Ali MK;Nhim K;Rolka DB;Albright AL
通讯作者：
Albright AL
DOI：
10.1016/s2213-8587(18)30027-5
发表时间：
2018-05
期刊：
The lancet. Diabetes & endocrinology
影响因子：
--
作者：
Ali MK;Bullard KM;Saydah S;Imperatore G;Gregg EW
通讯作者：
Gregg EW
影响因子：
168.9
作者：
Hall, Kevin D.;Sacks, Gary;Chandramohan, Dhruva;Chow, Carson C.;Wang, Y. Claire;Gortmaker, Steven L.;Swinburn, Boyd A.
通讯作者：
Swinburn, Boyd A.